E Fund Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.29M Buy
28,709
+2,510
+10% +$585K 0.16% 71
2026
Q1
$6.4M Buy
+26,199
New +$6.1M 0.19% 71
2025
Q2
$4.08M Sell
26,722
-6,079
-19% -$934K 0.19% 72
2025
Q1
$5.44M Buy
32,801
+4,425
+16% +$692K 0.26% 58
2024
Q4
$4.1M Buy
28,376
+11,181
+65% +$1.73M 0.21% 61
2024
Q3
$2.79M Buy
17,195
+1,022
+6% +$163K 0.14% 72
2024
Q2
$2.36M Buy
16,173
+1,755
+12% +$261K 0.13% 76
2024
Q1
$2.28M Buy
14,418
+9,658
+203% +$1.54M 0.14% 70
2023
Q4
$746K Buy
4,760
+452
+10% +$69.3K 0.05% 105
2023
Q3
$671K Sell
4,308
-617
-13% -$102K 0.05% 103
2023
Q2
$815K Sell
4,925
-581
-11% -$93.8K 0.06% 90
2023
Q1
$853K Sell
5,506
-159
-3% -$25.7K 0.06% 94
2022
Q4
$1M Sell
5,665
-445
-7% -$76.8K 0.08% 90
2022
Q3
$998K Buy
6,110
+312
+5% +$52.8K 0.09% 89
2022
Q2
$1.03M Buy
5,798
+28
+0.5% +$4.99K 0.09% 87
2022
Q1
$1.02M Sell
5,770
-783
-12% -$133K 0.03% 86
2021
Q4
$1.12M Sell
6,553
-3
-0% -$491 0.04% 102
2021
Q3
$1.06M Buy
+6,556
New +$1.12M 0.04% 88
2021
Q1
$860K Buy
+5,234
New +$847K 0.07% 98

Other funds holding JNJ

E Fund Management's JNJ Position: Q2 2026 in Review

E Fund Management increased its Johnson & Johnson (JNJ) stake by 9.6% in Q2 2026, buying an estimated $585K and bringing the position to 28,709 shares worth $7.29M. The position accounts for 0.16% of the portfolio, ranked #71.

E Fund Management first reported a position in JNJ in Q1 2021 and has held it in 19 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • E Fund Management held 28,709 shares of Johnson & Johnson worth $7.29M as of Q2 2026.
  • E Fund Management bought 2,510 Johnson & Johnson shares in Q2 2026, an estimated $585K.
  • Johnson & Johnson made up 0.16% of E Fund Management's portfolio in Q2 2026, its #71 holding.
  • E Fund Management first reported a position in Johnson & Johnson in Q1 2021 and has held it in 19 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.